TechFlow news, August 20, the A-share innovative drug sector opened significantly higher. Hansen Pharmaceutical and Halisan achieved 2 consecutive limit-ups; Haixin Shares, Zhongguancun, Laimai Pharmaceutical, Watson Biologics, Keyue Technology, Shuanglu Pharmaceutical, Kechen Pharmaceutical, and Yuekang Pharmaceutical hit limit-ups; Sanyuan Gene rose over 20%; Zhifei Biological and CSPC Innovation rose over 15%; Xinkaiyuan, Anke Biological, and Kangtai Biological rose over 10%. On the news front, US stock Moderna surged 177% overnight; the company and Merck announced that the melanoma skin cancer vaccine met its targets in a large-scale trial. (Jin10)
Add to Favorites
Share to Social Media





